Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
ABTC · Nasdaq · United States · Finance Services
In shortAmerican Bitcoin Corp. is loss-making.
Financial health
Mixed
Built from five areas over the last five annual reports. Tap an area to see the figures behind it. Bank or insurer: tests that do not apply to them are left out.
| Operating marginShare of each sale left after running the business, before interest and tax. | -123.1% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -82.7% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -18.2% | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -43.0% | n/a |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 0 of 5 | n/a |
Weight in the score: 20%
| Profitable years (last 5) | 2 of 5 | 40/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 162.5% | 0/100 |
| Operating margin volatility | 389.7% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 138.5% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
3 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 18 | 14 | 65 | 72 | 185 |
| Cost of revenue | 7.4 | 4.9 | 44 | 40 | 92 |
| Gross profit | 10 | 5.5 | 3.4 | 32 | 93 |
| Research & development | 5.9 | 4.1 | 2.3 | – | – |
| Operating income | (33) | (43) | 6.2 | 484 | (228) |
| Interest expense | – | – | 8.8 | 3.5 | – |
| Pre-tax income | (33) | (47) | 21 | 493 | (171) |
| Income tax | (2.3) | (0.7) | (19) | 60 | (18) |
| Net income | (31) | (79) | 40 | 429 | (153) |
| Diluted EPS | −$1.22 | −$546.56 | $0.04 | $0.49 | −$0.17 |
| Diluted shares (millions) | 26 | 0.1 | 892 | 892 | 905 |
3 older years available with the 10-year history. Essential plan, from €8.25/month →
Not computed: the model does not apply to banks and insurers.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 3, 2026